Stay updated on Blinatumomab & Pembrolizumab in B-ALL Clinical Trial

Sign up to get notified when there's something new on the Blinatumomab & Pembrolizumab in B-ALL Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Blinatumomab & Pembrolizumab in B-ALL Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    The page shows an addition of Revision: v3.4.1 and a deletion of Revision: v3.4.0. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-02-04T22:58:35.000Z thumbnail image
  2. Check
    10 days ago
    Change Detected
    Summary
    Glossary display option added and QC-related metadata updated to show Last Update Submitted that Met QC Criteria and a revision footer with v3.4.0. The older QC wording (Last Update Submitted that met QC Criteria), No FEAR Act data, and Revision: v3.3.4 text were removed.
    Difference
    0.2%
    Check dated 2026-01-28T21:48:44.000Z thumbnail image
  3. Check
    18 days ago
    No Change Detected
  4. Check
    25 days ago
    Change Detected
    Summary
    The page revision updated from v3.3.3 to v3.3.4. No visible changes were made to study details or layout.
    Difference
    0.1%
    Check dated 2026-01-14T04:42:16.000Z thumbnail image
  5. Check
    46 days ago
    Change Detected
    Summary
    Added a Locations section with California sites for this study. Page revision updated to v3.3.3.
    Difference
    0.2%
    Check dated 2025-12-23T23:16:32.000Z thumbnail image
  6. Check
    74 days ago
    Change Detected
    Summary
    Revision: v3.3.2 was added and Revision: v3.2.0 was removed from the page. This is a version update and does not modify the study details or other user-facing content.
    Difference
    0.1%
    Check dated 2025-11-25T13:43:47.000Z thumbnail image
  7. Check
    82 days ago
    Change Detected
    Summary
    Administrative date-stamp updates have been added (Results First Posted [Estimated], Certification/Extension First Posted [Estimated], Last Update Posted [Estimated]), and a funding-status notice has been removed. These changes do not affect the study details, eligibility, or results.
    Difference
    0.7%
    Check dated 2025-11-18T07:23:42.000Z thumbnail image

Stay in the know with updates to Blinatumomab & Pembrolizumab in B-ALL Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Blinatumomab & Pembrolizumab in B-ALL Clinical Trial page.